top of page

MENU

Passion Creates Innovation

R&D

Targeted Protein Degradation (TPD)

Cells have protein degradation systems (ubiquitin-proteasome degradation system, lysosome-autophagy degradation system) that remove damaged or unnecessary proteins to maintain homeostasis.

LEADERSHIP

Our Vision & Mission

PROTIER Biotech is leading the way in developing treatments for incurable diseases through innovative biotechnology. Dr. Hyuntae Kim is dedicated to realizing PROTIER Biotech's vision and mission.

R&D

ADC payload

Molecular Glue Degraders are small molecule drugs that have excellent drug properties, are easy to connect with linkers, and have the advantage of being effective even at low drug concentrations. Additionally, its small molecular weight makes it suitable for manufacturing.

Newsroom

01

The 13th regular general shareholders' meeting held

02

신규 CDO 플랫폼 에스-텐시파이 출시 '고객 맞춤' 전략으로 경쟁력 강화

03

'23 3rd quarter CEO IR Newsletter

04

'24 Q1 CEO IR Newsletter

bottom of page